Nagoya's Nakagawa Ward: 'Metallo-Balance Test' for Cancer and Cognitive Risk Assessment with Just 6mL Blood Sample Launches at Anpo Clinic on July 24, 2026
Key facts
- Nagoya's Nakagawa Ward: 'Metallo-Balance Test' for Cancer and Cognitive Risk Assessment with Just 6mL Blood Sample Launches at Anpo Clinic on July 24, 2026
- Renatech announces the launch of its 'Metallo-Balance Test'—a screening test that assesses cancer and MCI risk using only 6mL of blood—at Anpo Clinic in Nagoya's Nakagawa Ward starting July 24, 2026. This innovative test offers a new, accessible option for preventive healthcare.
- Source: PR TIMES
- Date: Thu Jun 18 2026 00:22:54 GMT+0900 (Japan Standard Time)
Direct answer
Renatech announces the launch of its 'Metallo-Balance Test'—a screening test that assesses cancer and MCI risk using only 6mL of blood—at Anpo Clinic in Nagoya's Nakagawa Ward starting July 24, 2026. This innovative test offers a new, accessible option for preventive healthcare.
- Citation
- Nagoya's Nakagawa Ward: 'Metallo-Balance Test' for Cancer and Cognitive Risk Assessment with Just 6mL Blood Sample Launches at Anpo Clinic on July 24, 2026 (Thu Jun 18 2026 00:22:54 GMT+0900 (Japan Standard Time)), PR TIMES
- Source
- PR TIMES
- Date
- Thu Jun 18 2026 00:22:54 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
Renatech announces the launch of its 'Metallo-Balance Test'—a screening test that assesses cancer and MCI risk using only 6mL of blood—at Anpo Clinic in Nagoya's Nakagawa Ward starting July 24, 2026. This innovative test offers a new, accessible option for preventive healthcare.
AI Analysis
Frequently Asked Questions
- Q: What is the Metallo-Balance Test?
- A: A screening test that analyzes 17 trace elements in blood to assess cancer and MCI risk.
- Q: When does the test start at Anpo Clinic?
- A: From July 24, 2026, every Friday and Saturday.
- Q: How can I take the test?
- A: Reserve via Renatech's website or hotline. No direct clinic contact.
- Q: How much does the test cost?
- A: Cancer or cognitive risk test: ¥19,800; both: ¥24,200 (tax included).
- Q: Who can take the test?
- A: Japanese nationals aged 20–80. Not for pregnant, cancer treatment, or dialysis patients.